Skip to main content
. 2019 Dec 18;14(12):e0225540. doi: 10.1371/journal.pone.0225540

Table 5. Intention to treat results for outcome data.

Week 9
Relative Risk (CI)
Week 21
Relative Risk (CI)
RR without time interaction term of 9 week and 21 weeks, if it is not significant
Average pain 1.03 (0.92, 1.15) 0.98 (0.88, 1.08) 1.00 (0.92, 1.08)
BPI Interferenceᵖ 1.00 (0.86, 1.16) 1.17 (0.99,1.37) 1.06 (0.96, 1.18)
BPI Severity 1.00 (0.89, 1.13) 1.01 (0.90, 1.14) 1.01 (0.92, 1.10)
PHQ-9 1.09 (0.92, 1.28) 0.89 (0.75, 1.06) Interaction is significant
Pain Self Efficacy 1.09 (0.96, 1.25) 0.93 (0.83, 1.05) Interaction is significant
Patient Activation Measure 0.99 (0.92, 1.07) 1.00 (0.93, 1.08) Interaction is significant
SF-12 Physical Composite Score 1.01 (0.92, 1.12) 0.86 (0.77, 0.97)* Interaction is significant
SF-12 Mental Composite Score 1.01 (0.95, 1.07) 1.07 (1.01, 1.12)* 1.02 (0.96, 1.08)
Current Opioid Misuse Measure 1.14 (0.92, 1.42) 1.13 (0.91, 1.40) 1.20 (1.10, 1.42)
Pain medication in the last 7 days
(Odds Ratio)
0.75 (0.33, 1.68) 0.42 (0.18, 0.98)* Interaction is significant
ED use 0.31 (0.10, 0.89)* 0.85 (0.32, 2.22) 0.72 (0.41,1.26)

ᵖ Poisson Model was used for this outcome variable.

† Negative Binomial Model was used for this outcome variable.

ᴸ Log Normal Model was used for this outcome variable.

OR Logistic regression model was use for this outcome variable. The results are OR (95%CI).

* Results are statistically significant and 95% Confidence Intervals (CI) does not include the number 1. All models were adjusted for COMM, PAM and this table shows the “9 week” and “21 week” results. The control group as well as the baseline outcomes were set as reference groups.